Ann: Results of Scheme Meeting, page-243

@Taurean7 thank you for your response. I most definitely feel that my interests as a shareholder were damaged by the scheme of arrangement methodology being employed rather than Pfizer making a competitive on- market tilt at ResApp by purchasing shares just the same way we all do.
My guess is that we would have been looking at a share price anywhere between $0.70 and $3 50 by now..
Got to get back to delivering Uber eats now thanks very much Pfizer.